Bausch Health Companies Inc(BHC) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Current Price

$28.03

RSI

23.026

Beta:

1.729178

November 03, 2020
24.3B
174M

-3.214 %
-1.010 %
213.636 %
-106.366 %

$8,601,000,000
$8,380,000,000
$8,724,000,000
$9,674,000,000
$10,446,500,000
$8,263,500,000
2.637 %
-4.105 %
-10.890 %
-7.985 %
26.417 %

$-1,837,000,000
$-4,154,000,000
$-1,741,000,000
$-2,435,000,000
$-155,300,000
$1,092,600,000
126.130 %
-58.089 %
39.862 %
-93.622 %
-803.542 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.